BlossomHill Therapeutics
Operator of a biopharmaceutical company designed to develop treatments for oncology and autoimmune diseases. The company offers innovative drug design expertise and precision medicine approaches, enab...
Valuation
$413.1M
Latest known
Share Price
N/A
Total Raised
$257.1M
Last Round
N/A